通过级联催化-氧还原反应对瘤特异性基斯普拉丁的现场激活,以实现高效的化疗-免疫治疗
Gang-Gang Yang1, Bin Liu2, Wei Liu1
1School of Chemistry and Chemical Engineering Anhui University of Technology, Ma'anshan, Anhui, 243002, P.R. China.
Angewandte Chemie (International ed. in English)
|May 4, 2025
概括
一种新的制药纳米药物,PtNP@Cu,通过诱导铁亡,实现瘤特异性激活,并增强化疗. 这种方法克服了的耐药性,改善了治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 癌症治疗 癌症治疗
背景情况:
- 基于的化疗面临的局限性包括药物利用率低,严重的副作用和获得的耐药性.
- 开发有针对性的药物输送系统对于提高治疗疗效和最大限度地减少非目标毒性至关重要.
研究的目的:
- 开发一种双锁保护(II) 纳米药物,PtNP@Cu,用于瘤特异激活和增强癌症治疗.
- 调查涉及级联解锁,铁灭菌诱导和克服抗性的作用机制.
主要方法:
- 合成和描述具有双锁保护机制的PtNP@Cu纳米药物.
- 在体外和体内研究评估瘤特异性药物激活,细胞吸收和治疗疗效.
- 评估铁灭菌诱导,谷氨耗尽,ROS生成和免疫反应.
主要成果:
- PtNP@Cu通过催化-氧化还原反应在细胞核中有效的瘤特异性激活西斯普拉丁 (cDDP).
- 纳米药物通过耗尽谷氨和增加活性氧物种 (ROS) 来诱导癌细胞中的显著铁亡.
- PtNP@Cu有效地克服了抗性,增强了抗瘤免疫力,并在体内显示出高治疗效率.
结论:
- 开发的PtNP@Cu纳米医学为解决传统制药的局限性提供了一个有希望的策略.
- 这种方法使瘤特异化疗和化疗免疫疗法成为可能,从而改善治疗结果.
- 级联解锁和铁灭诱导机制为癌症治疗提供了一条新的途径.
相关概念视频
Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


